Benjamin James Greene, MD - Medicare Otolaryngology in Birmingham, AL

Benjamin James Greene, MD is a medicare enrolled "Otolaryngology" physician in Birmingham, Alabama. He graduated from medical school in 2009 and has 15 years of diverse experience with area of expertise as Otolaryngology. He is a member of the group practice University Of Alabama Health Services Foundation, Pc and his current practice location is 2000 6th Ave S, Birmingham, Alabama. You can reach out to his office (for appointments etc.) via phone at (205) 934-9999.

Benjamin James Greene is licensed to practice in Alabama (license number 33306) and he also participates in the medicare program. He accepts medicare assignments (which means he accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and his NPI Number is 1154563898.

Contact Information

Benjamin James Greene, MD
2000 6th Ave S,
Birmingham, AL 35233-2110
(205) 934-9999
Not Available



Physician's Profile

Full NameBenjamin James Greene
GenderMale
SpecialityOtolaryngology
Experience15 Years
Location2000 6th Ave S, Birmingham, Alabama
Accepts Medicare AssignmentsYes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.
  Medical Education and Training:
  • Benjamin James Greene graduated from medical school in 2009
  NPI Data:
  • NPI Number: 1154563898
  • Provider Enumeration Date: 03/26/2009
  • Last Update Date: 01/31/2024
  Medicare PECOS Information:
  • PECOS PAC ID: 6901022722
  • Enrollment ID: I20140730002049

Medical Identifiers

Medical identifiers for Benjamin James Greene such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1154563898NPI-NPPES

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
207Y00000XOtolaryngology 33306 (Alabama)Primary

Medical Facilities Affiliation

Facility NameLocationFacility Type
University Of Alabama HospitalBirmingham, ALHospital

Group Practice Association

Group Practice NameGroup PECOS PAC IDNo. of Members
University Of Alabama Health Services Foundation, Pc19512131072344

News Archive

Antidepressant stops growth of plaques in mouse model of Alzheimer's disease

A commonly prescribed antidepressant can reduce production of the main ingredient in Alzheimer's brain plaques, according to new research at Washington University School of Medicine in St. Louis and the University of Pennsylvania.

MJFF selects Epitomics to distribute LRRK2 monoclonal antibodies

Epitomics, Inc. today announced that The Michael J. Fox Foundation for Parkinson's Research (MJFF) has chosen the company to distribute a panel of LRRK2 monoclonal antibodies that were developed under an agreement between the two parties. Under a special arrangement the antibodies are being provided at low cost to the entire PD research community to help advance LRRK2 therapeutic development efforts. The antibodies will be available to Parkinson's researchers in academic/nonprofit and industry labs on a worldwide basis.

Scientists have identified genes that promote the growth and recurrence of skin cancer

Dr. Andrzej Dlugosz and colleagues at the University of Michigan and the National Cancer Institute have examined the functions of the Hedgehog (Hh) signaling pathway in basal cell carcinoma, the most common form of cancer, and have uncovered a subset of tumor cells that are resistant to inhibition of the Hh pathway.

Researchers present more findings for microbicides, prep at M2010 conference

Researchers on Monday at the International Microbicides Conference in Pittsburgh continued to present data on HIV prevention research, Reuters reports. The news service outlines several prevention methods being researched, including an intravaginal ring that over time releases two antiretrovirals - dapivirine and maraviroc - for up to a month, and a vaginal tablet that time-releases the antiretrovirals dapivirine and DS003 for up to 12 hours.

Agilent introduces new microarray platform to study genetic basis of developmental disorders

Agilent Technologies Inc. today introduced the SurePrint G3 Human CGH+SNP microarray platform, an innovative system for simultaneous analysis of chromosomal copy number changes and copy-neutral aberrations. The system allows researchers to study the genetic basis of developmental disorders as well as many cancers.

Read more Medical News

› Verified 3 days ago

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Benjamin James Greene allows following entities to bill medicare on his behalf.
Entity NameUniversity Of Alabama Health Services Foundation, Pc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1093768723
PECOS PAC ID: 1951213107
Enrollment ID: O20031105000261

News Archive

Antidepressant stops growth of plaques in mouse model of Alzheimer's disease

A commonly prescribed antidepressant can reduce production of the main ingredient in Alzheimer's brain plaques, according to new research at Washington University School of Medicine in St. Louis and the University of Pennsylvania.

MJFF selects Epitomics to distribute LRRK2 monoclonal antibodies

Epitomics, Inc. today announced that The Michael J. Fox Foundation for Parkinson's Research (MJFF) has chosen the company to distribute a panel of LRRK2 monoclonal antibodies that were developed under an agreement between the two parties. Under a special arrangement the antibodies are being provided at low cost to the entire PD research community to help advance LRRK2 therapeutic development efforts. The antibodies will be available to Parkinson's researchers in academic/nonprofit and industry labs on a worldwide basis.

Scientists have identified genes that promote the growth and recurrence of skin cancer

Dr. Andrzej Dlugosz and colleagues at the University of Michigan and the National Cancer Institute have examined the functions of the Hedgehog (Hh) signaling pathway in basal cell carcinoma, the most common form of cancer, and have uncovered a subset of tumor cells that are resistant to inhibition of the Hh pathway.

Researchers present more findings for microbicides, prep at M2010 conference

Researchers on Monday at the International Microbicides Conference in Pittsburgh continued to present data on HIV prevention research, Reuters reports. The news service outlines several prevention methods being researched, including an intravaginal ring that over time releases two antiretrovirals - dapivirine and maraviroc - for up to a month, and a vaginal tablet that time-releases the antiretrovirals dapivirine and DS003 for up to 12 hours.

Agilent introduces new microarray platform to study genetic basis of developmental disorders

Agilent Technologies Inc. today introduced the SurePrint G3 Human CGH+SNP microarray platform, an innovative system for simultaneous analysis of chromosomal copy number changes and copy-neutral aberrations. The system allows researchers to study the genetic basis of developmental disorders as well as many cancers.

Read more Medical News

› Verified 3 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Benjamin James Greene is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Benjamin James Greene, MD
Po Box 55310,
Birmingham, AL 35255-5310

Ph: (205) 731-9701
Benjamin James Greene, MD
2000 6th Ave S,
Birmingham, AL 35233-2110

Ph: (205) 934-9999

News Archive

Antidepressant stops growth of plaques in mouse model of Alzheimer's disease

A commonly prescribed antidepressant can reduce production of the main ingredient in Alzheimer's brain plaques, according to new research at Washington University School of Medicine in St. Louis and the University of Pennsylvania.

MJFF selects Epitomics to distribute LRRK2 monoclonal antibodies

Epitomics, Inc. today announced that The Michael J. Fox Foundation for Parkinson's Research (MJFF) has chosen the company to distribute a panel of LRRK2 monoclonal antibodies that were developed under an agreement between the two parties. Under a special arrangement the antibodies are being provided at low cost to the entire PD research community to help advance LRRK2 therapeutic development efforts. The antibodies will be available to Parkinson's researchers in academic/nonprofit and industry labs on a worldwide basis.

Scientists have identified genes that promote the growth and recurrence of skin cancer

Dr. Andrzej Dlugosz and colleagues at the University of Michigan and the National Cancer Institute have examined the functions of the Hedgehog (Hh) signaling pathway in basal cell carcinoma, the most common form of cancer, and have uncovered a subset of tumor cells that are resistant to inhibition of the Hh pathway.

Researchers present more findings for microbicides, prep at M2010 conference

Researchers on Monday at the International Microbicides Conference in Pittsburgh continued to present data on HIV prevention research, Reuters reports. The news service outlines several prevention methods being researched, including an intravaginal ring that over time releases two antiretrovirals - dapivirine and maraviroc - for up to a month, and a vaginal tablet that time-releases the antiretrovirals dapivirine and DS003 for up to 12 hours.

Agilent introduces new microarray platform to study genetic basis of developmental disorders

Agilent Technologies Inc. today introduced the SurePrint G3 Human CGH+SNP microarray platform, an innovative system for simultaneous analysis of chromosomal copy number changes and copy-neutral aberrations. The system allows researchers to study the genetic basis of developmental disorders as well as many cancers.

Read more News

› Verified 3 days ago


Otolaryngology Doctors in Birmingham, AL

Dr. Grayson K Rodgers, M.D.
Otolaryngology
Medicare: Accepting Medicare Assignments
Practice Location: 2700 10th Ave S Ste 502, Birmingham, AL 35205
Phone: 205-933-2951    Fax: 205-933-5893
Dr. Jessica Warren Grayson, M.D.
Otolaryngology
Medicare: Accepting Medicare Assignments
Practice Location: 619 19th St S, Birmingham, AL 35249
Phone: 205-934-4011    
Brian Kulbersh, MD
Otolaryngology
Medicare: Not Enrolled in Medicare
Practice Location: 1940 Elmer J Bissell Rd, Birmingham, AL 35243
Phone: 205-638-4949    Fax: 205-638-4982
Dr. Richard Kailean Mchugh, MD, PHD
Otolaryngology
Medicare: Accepting Medicare Assignments
Practice Location: 2000 6th Ave S, The Kirklin Clinic, Birmingham, AL 35233
Phone: 205-801-8000    
Paul F Castellanos, MD
Otolaryngology
Medicare: Accepting Medicare Assignments
Practice Location: 619 19th Street South, Birmingham, AL 35233
Phone: 205-934-6600    
Dr. David Michael Walters, MD
Otolaryngology
Medicare: Accepting Medicare Assignments
Practice Location: 1809 Gadsden Hwy, Birmingham, AL 35235
Phone: 205-838-3755    Fax: 205-838-3755
Do Yeon Cho,
Otolaryngology
Medicare: Accepting Medicare Assignments
Practice Location: 2000 6th Ave S, Birmingham, AL 35233
Phone: 205-934-9999    

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.